Next-Generation Sequencing for Congenital Nephrotic Syndrome: A Multi-Center Cross-Sectional Study from India
Aditi Joshi(Institute of Genomics and Integrative Biology), Arvind Bagga(All India Institute of Medical Sciences), Monica Chandan(All India Institute of Medical Sciences), Uzma Shamim(Institute of Genomics and Integrative Biology), Shaista Parveen, Mitali Mukerji(Indian Institute of Technology Jodhpur), Mohammed Faruq(Institute of Genomics and Integrative Biology), Aradhana Mathur(Institute of Genomics and Integrative Biology), Pankaj Hari(Indian Council of Medical Research), Aditi Sinha, Pooja Sharma(Institute of Genomics and Integrative Biology), Aakanksha Sharma(Post Graduate Institute of Medical Education and Research), Bharathram Uppilli(Institute of Genomics and Integrative Biology), Priyanka Khandelwal(Chacha Nehru Bal Chikitsalaya), Sana Zahra(Institute of Genomics and Integrative Biology), Prachi Tewari(All India Institute of Medical Sciences)
Cited by 12
Related Papers
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203